Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital

被引:34
作者
Buajordet, I [1 ]
Wesenberg, F [1 ]
Brors, O [1 ]
Langslet, A [1 ]
机构
[1] Univ Oslo, Ullevaal Hosp, Dept Paediat, N-0407 Oslo, Norway
关键词
adverse drug events; children; hospitalized and discharge; intensive monitoring;
D O I
10.1080/080352502753458021
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The frequency and characteristics of adverse drug events (ADEs) in children hospitalized in the paediatric department of Ullevaal University Hospital, Norway, were determined using intensive monitoring. Of 579 children treated with drugs, 28% experienced ADEs; 7% at the time of admission, 18% during hospitalization and 9% after discharge. All children treated for cancer, 19% treated with anti-infective drugs, 15% treated with antiasthmatics and 10% treated with drugs affecting the nervous system experienced ADEs. The most frequent events were gastrointestinal, CNS- and skin reactions and 19% were considered as serious. ADEs caused 6% of the admissions and 44% required interventions. Most ADEs were found by screening patient records, where physicians mostly described adverse drug events requiring interventions and nurses described less serious events. Parents reported l4% of the events. of which a majority were CNS reactions. CNS reactions may be more common than expected and observations by parents are important when investigating such reactions in children. Conclusions: ADEs. mainly gastrointestinal, CNS and skin reactions related to drugs affecting the nervous system, anti-infectives and antiasthmatics, were seen in 28% of the patients. The reporting of events by parents was a useful supplement to the screening of patient records.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 27 条
[1]   Computerized surveillance of adverse drug reactions in hospital: pilot study [J].
Azaz-Livshits, T ;
Levy, M ;
Sadan, B ;
Shalit, M ;
Geisslinger, G ;
Brune, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (03) :309-314
[2]   RELATIONSHIP BETWEEN MEDICATION ERRORS AND ADVERSE DRUG EVENTS [J].
BATES, DW ;
BOYLE, DL ;
VLIET, MVV ;
SCHNEIDER, J ;
LEAPE, L .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1995, 10 (04) :199-205
[3]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[4]   INTENSIVE MONITORING OF ADVERSE DRUG-REACTIONS IN INFANTS AND PRESCHOOL-CHILDREN [J].
CIRKOBEGOVIC, A ;
VRHOVAC, B ;
BAKRAN, I .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (01) :63-65
[5]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851
[6]   PROSPECTIVE STUDY OF EPIDEMIOLOGY OF ADVERSE DRUG-REACTIONS IN PEDIATRIC HEMATOLOGY AND ONCOLOGY PATIENTS [J].
COLLINS, GE ;
CLAY, MM ;
FALLETTA, JM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1974, 31 (10) :968-975
[7]   Unlicensed and off label drug use in neonates [J].
Conroy, S ;
McIntyre, J ;
Choonara, I .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1999, 80 (02) :F142-F144
[8]   Survey of unlicensed and off label drug use in paediatric wards in European countries [J].
Conroy, S ;
Choonara, I ;
Impicciatore, P ;
Mohn, A ;
Arnell, H ;
Rane, AR ;
Knoeppel, C ;
Seyberth, H ;
Pandolfini, C ;
Raffaelli, MP ;
Rocchi, F ;
Bonati, M ;
't Jong, G ;
de Hoog, M ;
van den Anker, J .
BRITISH MEDICAL JOURNAL, 2000, 320 (7227) :79-82
[9]   THE INCIDENT REPORTING SYSTEM DOES NOT DETECT ADVERSE DRUG EVENTS - A PROBLEM FOR QUALITY IMPROVEMENT [J].
CULLEN, DJ ;
BATES, DW ;
SMALL, SD ;
COOPER, JB ;
NEMESKAL, AR ;
LEAPE, LL .
JOINT COMMISSION JOURNAL ON QUALITY IMPROVEMENT, 1995, 21 (10) :541-548
[10]  
Dharnidharka V R, 1993, Indian Pediatr, V30, P745